AI foundation models
Coverage of AI foundation models in the Nexus archive.
- STAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics
Alnylam partners with Inceptive Nucleics to develop AI foundation models for RNAi therapeutics. The three-year collaboration is worth up to $2 billion, with $30 million upfront in cash and equity. Jakob Uszkoreit, former Google researcher, co-founded Inceptive Nucleics after contributing to foundational AI research.
- Insilico teams up with US firm to build AI models predicting disease decades ahead
Insilico Medicine, a Hong Kong-listed AI drug-discovery company, has partnered with US-based Human Longevity to develop large-scale AI foundation models capable of predicting diseases like cancer decades before symptoms appear. The collaboration aims to leverage advancements in AI and the growing $5.3 trillion global longevity market driven by aging populations.
- Insilico teams up with US firm to build AI models predicting disease decades ahead
Insilico Medicine, a Hong Kong-listed AI drug-discovery company, has partnered with US-based Human Longevity to develop large-scale AI foundation models capable of predicting diseases like cancer decades before symptoms appear. The collaboration aims to leverage the growing global longevity market, valued at $5.3 trillion.